To determine the potential interaction between panitumumab and FTD in EGFR signaling, we analyzed the phosphorylation status of signaling mediators ERK and AKT in FTD‐treated colon cancer cells using western blotting. The gene discussed is MAPK1; the disease is colonic neoplasm.